TARAArTara TherapeuticsTARA info
$1.92info5.49%24h
Global rank29632
Market cap$21.82M
Change 7d2.13%
YTD Performance2.67%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    ArTara Therapeutics (TARA) Stock Overview

    Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. The company is headquartered in New York, New York.

    TARA Stock Information

    Symbol
    TARA
    Address
    345 Park Avenue SouthNew York, NY 10010United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.protaratx.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    646 844 0337

    ArTara Therapeutics (TARA) Price Chart

    -
    Value:-

    ArTara Therapeutics Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.92
    N/A
    Market Cap
    $21.82M
    N/A
    Shares Outstanding
    11.36M
    N/A
    Employees
    25.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org